The Global Molecular Diagnostics Market Report by Koncept Analytics. For more : vikas@konceptanalytics.com

1. Global Molecular Diagnostics Market Report
-----------------------------------------
2014
View Report Details

2. Executive Summary
Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological
sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient
samples, including blood and tissues, in order to detect the presence of concerning physiological/pathological state, or concerning congenital
abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the title of ‘silent champion’ of the healthcare industry since this segment
influences more than half of the decision-making in the overall healthcare industry.
Under this umbrella, the fastest growing segment, i.e. molecular diagnostics, involves performing analysis at the molecular level, and thereby
measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of
health or disease. Such diagnostic methods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and
specificity and thus, have been receiving greater inclination from physicians and affiliates.
The molecular diagnostics procedures for infectious diseases including CT/NG, HPV; encompasses four major disciplines: Virology,
Bacteriology, Genetics and Blood Screening. Due to certain underlying factors, the oncology segment of the market is poised to undergo
noteworthy expansion in the near future and thereby driving the molecular diagnostics market on the holistic basis. As of now, the global
molecular diagnostics market is characterized by growth in large value mergers and acquisitions, personalized treatment in the field of oncology
and reimbursement trend.
The report presents thorough analysis of the global molecular diagnostics market and its various segments and also provides detailed
information pertaining to its superset market, i.e. the diagnostics and the IVD industry. It further discusses the various trends, growth drivers and
challenges faced by the industry. In addition to the market contention prevalent in the global molecular diagnostics market, major industry
players including Roche Holdings, Novartis, Hologic and Qiagen are profiled herein.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have projected the future growth of the
industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to
determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor
variables and the dependent variable was analyzed using standard SPSS output.
View Report Details

3. The global molecular diagnostics market continues to be robust due to rising incidence of CT/NG disease
and favorable guidelines promoting blood screening segment…
 The global IVD market rose by …% to reach US$... billion in
2013.
 The global molecular diagnostics market increased to US$...
billion in 2013, which recorded a Y-O-Y growth of …% over
2012.
 In 2013, infectious disease testing accounted for …% of the
molecular diagnostic market while onco-hematology
accounted for …%.
 In 2013, the global HPV market is estimated to have reached
US$... million against 2012 level of US$... million.
 Global CT/NG market rose to an estimated US$... million in
2013 registering growth of …% over previous year.
Global Molecular Diagnostics Market (2009-2013)
2009 2010 2011 2012 2013
US$Billion
Global IVD Market (2009-2013)
Global CT/NG Market (2011-2015E)
2009 2010 2011 2012 2013
US$Billion
2011 2012 2013 2014E 2015E
US$Million

4. Other factors such as rising proportion of aged population, increasing demand for oncology diagnostics
and rising incidence of diabetes are also keeping the global molecular diagnostics market buoyant…
 The market for genetic testing stood at US$... billion in 2009 and
is estimated to have grown to US$... billion in 2013. .
 In 2012, …million Chlamydia cases and …thousand Gonorrhoea
cases were recorded in the US and the country accounts for …%
of the global CT/NG market.
 The year 2014 is likely to end with …thousand tumor patients in
the US and the same is expected to rise to almost …thousand
patients by the year 2020.
 In 2010, the total medical costs associated with different types of
cancer in the US were estimated to be about US$... billion and
the same is projected to reach US$... billion by 2020.
 The molecular diagnostics’ capacity has been on the rise as well
with the number of molecular laboratories increasing from ... in
2012 to …in 2013.
Oncology Patient Pool in the United States (2014-2018E)
Global Genetic Testing Market (2009-2013)
2008 2009 2010 2011 2012
Thousand
Rising Incidence of Chlamydia in the US (2008-2012)
2014 2015E 2016E 2017E 2018E
Thousand
2009 2010 2011 2012 2013
US$Billion

5. Rising healthcare expenditure, rising incidence of HPV disease, growing Point-of-Care diagnostics and
leaping penetration of Liquid Based Cytology Tests are the other chief factors that will drive the market…
• The global molecular diagnostics market is forecasted to grow at a CAGR of ….% and is expected to reach US$... billion by 2017.
• Rising demand of oncology diagnostics, waning price sensitiveness, an aging population across the OECD member countries and
China, rising incidence of infectious diseases, improving global economic conditions and increased consolidation are likely to keep
the global market robust in the medium term,
• Molecular Diagnostics growth is likely to be further fueled by rising medical costs associated with the diagnosis of various diseases
which the market caters to.
World Molecular Diagnostics Market Forecast, 2013-2017F
2013 2014F 2015F 2016F 2017F
US$Billion

6. Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Molecular Diagnostics
Market ”. To know more about this report or for any customized research requirement, please contact the following:
View Report Details